Kinaxis Inc. (TSE:KXS – Get Free Report) Senior Officer Andrew William Robert Bell sold 100 shares of Kinaxis stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of C$184.74, for a total transaction of C$18,474.00. Following the sale, the insider now owns 831 shares of the company’s stock, valued at approximately C$153,518.94. The trade was a 10.74 % decrease in their ownership of the stock.
Kinaxis Stock Down 0.4 %
KXS opened at C$181.25 on Wednesday. The company has a fifty day moving average of C$168.20 and a two-hundred day moving average of C$159.27. The stock has a market capitalization of C$5.12 billion, a price-to-earnings ratio of 181.96, a PEG ratio of 3.60 and a beta of 0.78. Kinaxis Inc. has a fifty-two week low of C$132.93 and a fifty-two week high of C$190.17. The company has a debt-to-equity ratio of 12.40, a quick ratio of 2.29 and a current ratio of 1.90.
Kinaxis (TSE:KXS – Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported C$0.47 earnings per share for the quarter, beating the consensus estimate of C$0.43 by C$0.04. The firm had revenue of C$165.79 million during the quarter, compared to analyst estimates of C$170.56 million. Kinaxis had a return on equity of 4.87% and a net margin of 4.59%. On average, research analysts expect that Kinaxis Inc. will post 4.2526231 earnings per share for the current year.
Analyst Upgrades and Downgrades
Get Our Latest Report on Kinaxis
Kinaxis Company Profile
Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. It offers RapidResponse, a cloud-based platform, which provides advanced planning, sales and operation planning, supply and demand planning, inventory management, and command and control center services.
Further Reading
- Five stocks we like better than Kinaxis
- How to Invest in Biotech Stocks
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- Which Wall Street Analysts are the Most Accurate?
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- What is the Nasdaq? Complete Overview with History
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.